<bill session="115" type="h" number="6294" updated="2019-04-18T16:25:46Z">
  <state datetime="2018-06-28">REFERRED</state>
  <status>
    <introduced datetime="2018-06-28"/>
  </status>
  <introduced datetime="2018-06-28"/>
  <titles>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to encourage the development of priority antimicrobial products through the award of a transferable exclusivity extension period, and for other purposes.</title>
    <title type="short" as="introduced">Re-Valuing Anti-Microbial Products Act of 2018</title>
    <title type="short" as="introduced">Re-Valuing Anti-Microbial Products Act of 2018</title>
    <title type="short" as="introduced">REVAMP Act</title>
    <title type="short" as="introduced">REVAMP Act</title>
    <title type="display">REVAMP Act</title>
  </titles>
  <sponsor bioguide_id="S000364"/>
  <cosponsors>
    <cosponsor bioguide_id="C001097" joined="2018-06-28"/>
    <cosponsor bioguide_id="E000215" joined="2018-07-24"/>
  </cosponsors>
  <actions>
    <action datetime="2018-06-28">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-06-28" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
